Briefly, the LH/FSH ratio and clinical and biochemical indicators of hyperandrogenism exhibited significant elevation in the patient group compared to those in the healthy cohort, while groups did not differ in demographic, anthropometric, or metabolic features. Here, BRD2 is linked to hyperandrogenism.